Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions?

« Previous Next »Human Pathology
Volume 37, Issue 3 , Pages 272-282, March 2006

Tarik Tihan, MD, PhD
- Department of Pathology, University of California at San Francisco, San Francisco, CA 94143-0511, USA
- Corresponding author. Department of Pathology, University of California at San Francisco Medical Center, San Francisco, CA 94143-0511, USA.
Justine Barletta, MD
- Department of Pathology, University of California at San Francisco, San Francisco, CA 94143-0511, USA
Ian Parney, MD
- Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143-0511, USA
Kathleen Lamborn, PhD
- Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143-0511, USA
Penny K. Sneed, MD
- Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA 94143-0511, USA
Susan Chang, MD
- Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143-0511, USA